In this study we analyzed the first cohort of Hungarian TSC NMI patients, in which no TSC1/TSC2 mutations were identified using Sanger sequencing and multiplex ligation dependent probe amplification (MLPA). This evidence concerns the gene TSC2 and tuberous sclerosis.